Please assess the completion status of the following clinical trial:

Trial Title: Use and Safety of the LUTONIX® Drug Coated Balloon Catheter in Arteries of the Lower Extremity

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. ≥ 18 years of age;~2. Rutherford Clinical Category ≤ 5;~3. Patient or Legally Authorized Representative is willing to provide informed consent and comply with the required follow up;~4. Stenotic or obstructive vascular lesions in artery(s) of the lower extremity;~5. Lesion(s) can be treated with available LUTONIX Drug Coated Balloon Catheter device size matrix per current country-specific IFU.~Exclusion Criteria:~1. Patient is currently participating in an active phase of another investigational drug or device study;~2. Inability to take recommended medications as stated in the IFU or non-controllable allergy to contrast.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Single Arm: Lutonix Drug Coated Balloon (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).